Pharma Focus Asia
Klöckner Pentaplast - Pentapharm® alfoil® films

Novel Agent Reactivates an Immune Call by LIF Blockade

Novel agent reactivates is a new therapy with dual mechanism of action to eliminate malignant stem cells and activate the immune system.

It is developed by Vall d´Hebron Institute of Oncology (VHIO), novel agent MSC-1 inhibits LIF and has now been shown to have a dual mechanism of action.

First, in tumours expressing high levels of LIF, this protein promotes the proliferation of cancer stem cells. LIF blockade eliminates these tumor-initiating stem cells, putting the brakes on metastatic cell spread and cancer recurrence.

Additionally, elevated LIF expression disables the anti-tumor alarm system and stops the immune system from thwarting cancer's plans. Blocking LIF reactivates the alarm to call an anti-tumoural immune response.

Pioneer of previous LIF studies, Joan Seoane and his team were the first to establish a link between this multi-functional protein and cancer as well as show that LIF blockade eliminates cancer stem cells and prevents disease progression and recurrence.

In this present paper, they have now revealed its implication in the immune system's anti-cancer response.

After several years of research and validating LIF's promise as a therapeutic target in preclinical and experimental models, Joan founded Mosaic Biomedicals, launched to identify, develop, potentiate and translate novel therapies into benefits for patients at the bedside as quickly as possible.

Mosaic has since brought the first-in-class MSC-1 LIF inhibitor closer to the clinic. This promising agent is currently being assessed in clinical trials for further development.

magazine-slider-imageBIOVIA from Molecule to MedicineMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024